| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Agents of shield: glycans mask antibody epitopes on ADAMTS13
|
Kretz, Colin A.
|
|
|
9 |
7 |
p. 1726-1727
|
artikel
|
| 2 |
Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies
|
Shahid, Sanam
|
|
|
9 |
7 |
p. 1644-1657
|
artikel
|
| 3 |
Anxiety and depression among patients newly diagnosed with lymphoma and myeloma
|
Odejide, Oreofe O.
|
|
|
9 |
7 |
p. 1618-1629
|
artikel
|
| 4 |
ATP citrate lyase is an essential player in the metabolic rewiring induced by PTEN loss during T-ALL development
|
Andrieu, Guillaume P.
|
|
|
9 |
7 |
p. 1670-1691
|
artikel
|
| 5 |
Best but not perfect: indirect measure of low iron stores
|
Njoku, Franklin
|
|
|
9 |
7 |
p. 1642-1643
|
artikel
|
| 6 |
Changes in gut microbiota predict neutropenia after induction treatment in childhood acute lymphoblastic leukemia
|
Sørum, Maria Ebbesen
|
|
|
9 |
7 |
p. 1508-1521
|
artikel
|
| 7 |
Desensitization to calaspargase pegol appears to be less successful than pegaspargase
|
Matherne, Milre
|
|
|
9 |
7 |
p. 1492-1496
|
artikel
|
| 8 |
Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas
|
Sarathkumara, Yomani D.
|
|
|
9 |
7 |
p. 1658-1669
|
artikel
|
| 9 |
Dual ASXL1 and CSF3R mutations drive myeloid-biased stem cell expansion and enhance neutrophil differentiation
|
Darmusey, Lucie
|
|
|
9 |
7 |
p. 1593-1607
|
artikel
|
| 10 |
Duration of primary/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis
|
Li, Anqi
|
|
|
9 |
7 |
p. 1742-1761
|
artikel
|
| 11 |
Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients: a multicenter study by ESID and EBMT IEWP
|
Fekadu-Siebald, Julia
|
|
|
9 |
7 |
p. 1702-1711
|
artikel
|
| 12 |
Fc mutagenesis enhances the functionality of anti-RhD monoclonal antibodies
|
Heydarchi, Behnaz
|
|
|
9 |
7 |
p. 1522-1533
|
artikel
|
| 13 |
Ferritin outperforms other biomarkers in predicting bone marrow iron stores in patients with hematologic disorders
|
Lahtiharju, Tapio
|
|
|
9 |
7 |
p. 1608-1617
|
artikel
|
| 14 |
Germ line JAK2 variants and hereditary blood cancers
|
Cannova, Joseph
|
|
|
9 |
7 |
p. 1585-1586
|
artikel
|
| 15 |
JAK2 p.R564 germ line variants associated with hereditary thrombocythemia and hematologic neoplasms
|
Stewart, Brittany L.
|
|
|
9 |
7 |
p. 1534-1543
|
artikel
|
| 16 |
Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels
|
Moia, Riccardo
|
|
|
9 |
7 |
p. 1692-1701
|
artikel
|
| 17 |
Nbeal2 knockout mice are not protected against hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension
|
Posey, Janelle N.
|
|
|
9 |
7 |
p. 1571-1584
|
artikel
|
| 18 |
N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTP
|
Postmus, Tim
|
|
|
9 |
7 |
p. 1728-1737
|
artikel
|
| 19 |
Outcomes of older adults and frail patients receiving idecabtagene vicleucel: a CIBMTR study
|
Akhtar, Othman Salim
|
|
|
9 |
7 |
p. 1587-1592
|
artikel
|
| 20 |
Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas
|
Chihara, Dai
|
|
|
9 |
7 |
p. 1485-1491
|
artikel
|
| 21 |
Pretransplant MRD does not seem to affect survival in NPM1-mutated AML undergoing allogeneic stem cell transplantation
|
Fraccaroli, Alessia
|
|
|
9 |
7 |
p. 1630-1641
|
artikel
|
| 22 |
Pretreatment pulmonary function testing has limited utility in B-cell lymphoma treated with CD19 CAR T cells
|
Sdayoor, Inbal
|
|
|
9 |
7 |
p. 1720-1725
|
artikel
|
| 23 |
Psychiatric and substance use disorders predict poor outcomes in older veterans with acute myeloid leukemia
|
Lee, Michelle H.
|
|
|
9 |
7 |
p. 1555-1558
|
artikel
|
| 24 |
Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year update
|
Kimby, Eva
|
|
|
9 |
7 |
p. 1712-1719
|
artikel
|
| 25 |
Solitary plasmacytoma: single-institution experience, and systematic review and meta-analysis of clinical outcomes
|
Charalampous, Charalampos
|
|
|
9 |
7 |
p. 1559-1570
|
artikel
|
| 26 |
Thalassemia carriers exhibit reduced expression of the receptor for the malarial parasite Plasmodium vivax on erythrocytes
|
Huang, Renliang
|
|
|
9 |
7 |
p. 1738-1741
|
artikel
|
| 27 |
The role of genetic sequencing in the diagnostic workup for chronic immune thrombocytopenia
|
Joshi, Nehal
|
|
|
9 |
7 |
p. 1497-1507
|
artikel
|
| 28 |
Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study
|
Wolach, Ofir
|
|
|
9 |
7 |
p. 1544-1554
|
artikel
|
Tijdschrift beschrijving